Matinas BioPharma Competitors and Similar CompaniesClear all
Matinas BioPharma's competitors and similar companies include Amarin, BioMarin Pharmaceutical, CSL Behring and Cadila Pharmaceuticals.
 Matinas BioPharma Matinas BioPharma is a biopharmaceutical company developing a drug candidate for the treatment of cardiovascular and metabolic conditions. |  Amarin Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases. |  BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. | ||
Founding Date | Founding Date 2011 | Founding Date 1991 | Founding Date 1997 | Founding Date 1904 | Founding Date 1951 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Bedminster, US HQ Raritan, US | Locations Dublin, IE HQ Zug, CH Bridgewater Township, US | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | |
Employees | Employees 2140% increase | Employees 275 | Employees 3,0015% increase | Employees 7,5692% decrease | Employees 8,5201% increase |
Valuation ($) | Valuation ($) 14 m | Valuation ($) 257.6 m | Valuation ($) 13.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $213.6m (FY, 2025) | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) N/A |
Gross profit | Gross profit N/A | Gross profit $120.9m (FY, 2025) | Gross profit $2.5b (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit N/A |
Net income | Net income ($10.3m) (FY, 2025) | Net income ($38.8m) (FY, 2025) | Net income $348.9m (FY, 2025) | Net income N/A | Net income N/A |
Operating ⚠ | |||||
Patent Applications | Patent Applications N/A | Patent Applications N/A | Patent Applications 426 (FY, 2016) | Patent Applications 3 (Dec, 2020) | Patent Applications N/A |
Funding | |||||
Total funding raised | Total funding raised $ 55m | Total funding raised $ 122.8m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Amarin
HQ
Dublin, IE
Employees
275
Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases.
View companyBioMarin Pharmaceutical
HQ
San Rafael, US
Employees
3,001↑ 5% increase
BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View company